Yoon Seung-kew is the director of Seoul St. Mary's Hospital, The Catholic University of Korea. He also serves as the director of Yeouido St. Mary's Hospital.
He was born on April 12, 1959.
He graduated from the College of Medicine at The Catholic University of Korea and obtained his master's and doctorate degrees in medicine from the same university's graduate school.
In 1992, he was appointed to the Department of Internal Medicine at The Catholic University of Korea.
He was a research fellow at the Cancer Center of Massachusetts General Hospital (MGH), Harvard Medical School in the United States.
He served as the president of the Korean Liver Cancer Association and is currently active as a research evaluator for the National Research Foundation of Korea and the director of the WHO Collaborating Center for Hepatitis in the Western Pacific Region.
After serving as the director of the Cancer Hospital at Seoul St. Mary's Hospital, he is now the director of both Seoul St. Mary's Hospital and Yeouido St. Mary's Hospital.
He is an authority in the field of liver cancer as a researcher who integrates clinical and basic science.
He led the establishment of the POSTECH-Catholic Biomedical Engineering Institute at The Catholic University of Korea, spearheading the development of new drugs and the discovery of biomarkers (diagnostic indicators).
By strengthening ESG management, he has established a symbiotic management model for domestic medical institutions and laid a collaborative foundation for expanding clinical support for research and development of new drugs and new medical technologies.
#YoonSeungkew #SeoulStMarysHospital #livercancer #medicalresearch #cancerresearch #ESGmanagement #biomedicalengineering #SouthKorea #newdrugdevelopment #biomarkers